Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Suspended 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 10Lymphoid 8Myeloid 2Classical hematology 2Tumor-Agnostic 1Plasma cell 1Gastrointestinal 1CNS 1

Conditions

Myelodysplastic Syndromes 144Leukemia, Myeloid, Acute 133Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67Leukemia 52Hodgkin Disease 49Lymphoma, Non-Hodgkin 47Multiple Myeloma 43Myeloproliferative Disorders 39Lymphoma 36Leukemia, Lymphocytic, Chronic, B-Cell 36Primary Myelofibrosis 24Leukemia, Biphenotypic, Acute 22Leukemia, Myelomonocytic, Chronic 21Hematologic Neoplasms 20Graft vs Host Disease 18Anemia, Refractory, with Excess of Blasts 17Anemia, Aplastic 14Lymphoma, Mantle-Cell 13Lymphoma, Follicular 13Lymphoma, B-Cell, Marginal Zone 13Burkitt Lymphoma 13Neoplasms, Plasma Cell 12Leukemia, Prolymphocytic 11Blast Crisis 10Polycythemia Vera 8Leukemia, Myelomonocytic, Juvenile 8Hematologic Diseases 8Leukemia, Lymphoid 7Thrombocythemia, Essential 6

Interventions

fludarabine phosphate 3Whole-Body Irradiation 3Melphalan 3Cyclophosphamide 3Azacitidine 3fludarabine 2Mycophenolic Acid 2Imatinib Mesylate 2venetoclax 1treosulfan 1tislelizumab 1thymoglobulin 1ruxolitinib 1pevonedistat 1peginterferon alfa-2a 1nilotinib 1Tyrosine Kinase Inhibitors 1Tacrolimus 1Sirolimus 1Rituximab 1Peripheral Blood Stem Cell Transplantation 1Maintenance 1Immune Checkpoint Inhibitors 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Decitabine 1Dasatinib 1Cord Blood Stem Cell Transplantation 1Clofarabine 1CT-P10 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasm, Residual × fludarabine × Myeloid × Clear all
NCT03494569 2026-03-18

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center

Phase 1 Suspended
36 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

M.D. Anderson Cancer Center

Phase 2 Completed
6 enrolled 10 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡